Fig. 2From: The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in poniesGlucose concentrations (mean ± SE) during a series of three combined glucose-insulin tolerance tests. Tests were conducted over 150 min, one wk. before treatment (A), after 16 wk. of daily treatment (B) and after 4 wk. of treatment withdrawal (C) in ponies given placebo (control; closed triangles) or velagliflozin (treated; open triangles) dailyBack to article page